Peter Johannes Holst

Peter Johannes Holst

Associate Professor

  • CMP

    Blegdamsvej 3B, 2200 København N, Building: 07-13-16

    Phone: +45 35 32 64 76Mobile: +45 23 64 95 87

Member of:

  • EXPVACC/LEV team


  1. 2020
  2. Published

    Cancer associated endogenous retroviruses: Ideal immune targets for adenovirus-based immunotherapy

    Bermejo, A. V., Ragonnaud, Emeline, Daradoumis, J. & Holst, Peter Johannes, 2020, In : International Journal of Molecular Sciences. 21, 14, p. 1-21 21 p., 4843.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans

    PEACHI Consortium, P. C., 2020, In : Science Translational Medicine. 12, 548, eaaz7715.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The potential of adenoviral vaccine vectors with altered antigen presentation capabilities

    Neukirch, L., Fougeroux, C., Andersson, A. M. C. & Holst, Peter Johannes, 2020, In : Expert Review of Vaccines. 19, 1, p. 25-41

    Research output: Contribution to journalReviewResearchpeer-review

  5. 2019
  6. Published

    CD8+T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine gamma-herpesvirus 68 infection

    Boilesen, Ditte Rahbæk, Ragonnaud, Emeline, Laursen, H., Andersson, A. C., Tolver, Anders, Spiess, K. & Holst, Peter Johannes, 2019, In : Vaccine. 37, 22, p. 2952-2959 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Modified MHC Class II-Associated Invariant Chain Induces Increased Antibody Responses against Plasmodium falciparum Antigens after Adenoviral Vaccination

    Fougeroux, C., Turner, Louise, Bojesen, Anders Miki, Lavstsen, Thomas & Holst, Peter Johannes, 2019, In : Journal of Immunology. 202, 8, p. 2320-2331

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine

    Schwerdtfeger, M., Andersson, A. M. C., Neukirch, L. & Holst, Peter Johannes, 2019, In : Journal of Translational Medicine. 17, 1, 18 p., 175.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2018
  10. Published

    Virus-like-vaccines against HIV

    Andersson, A. M. C., Schwerdtfeger, M. & Holst, Peter Johannes, Mar 2018, In : Vaccines. 6, 1, 17 p., 10.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae

    Antenucci, Fabio, Fougeroux, C., Deeney, A., Ørskov, Cathrine, Rycroft, A., Holst, Peter Johannes & Bojesen, Anders Miki, Jan 2018, In : Veterinary Research. 49, 1, 11 p., 4.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    EBI2 in splenic and local immune responses and in autoimmunity

    Barington, L., Wanke, F., Niss Arfelt, K., Holst, Peter Johannes, Kurschus, F. C. & Rosenkilde, Mette, 2018, In : Journal of Leukocyte Biology. 104, 2, p. 313-322 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

  13. Published

    Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques

    Ragonnaud, Emeline, Schroedel, S., Mariya, S., Iskandriati, D., Pamungkas, J., Fougeroux, C., Daradoumis, J., Thomsen, Allan Randrup, Neukirch, L., Ruzsics, Z., Salomon, M., Thirion, C. & Holst, Peter Johannes, 2018, In : Vaccine. 36, 41, p. 6212-6222 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 Next

ID: 7853